News Search

Based on Columbia research, an experimental drug for a rare type of ALS is being tested in a phase 3 clinical trial after a new study found that the drug lowered levels of a toxic protein.

Just a single type of neuron controls the complex patterns of walking, a surprising finding that may lead to new therapeutic approaches for people with spinal cord injuries.

New Columbia research suggests that targeting neighboring bone cells may be a better strategy than targeting malignant stem cells to treat acute myeloid leukemia.

Bariatric surgery is not the easy way out, but the only long-term, proven weight loss treatment we have, says Columbia surgeon Marc Bessler.